Results 201 to 210 of about 14,990 (249)
Some of the next articles are maybe not open access.
Allergy. European Journal of Allergy and Clinical Immunology, 2021
Allergic bronchopulmonary aspergillosis (ABPA) is a lung disease involving hypersensitivity to Aspergillus fumigatus (Af) antigens caused by repeated inhalation of spores in susceptible hosts.
Raphael Lukaszewicz +3 more
semanticscholar +1 more source
Allergic bronchopulmonary aspergillosis (ABPA) is a lung disease involving hypersensitivity to Aspergillus fumigatus (Af) antigens caused by repeated inhalation of spores in susceptible hosts.
Raphael Lukaszewicz +3 more
semanticscholar +1 more source
Allergic Bronchopulmonary Aspergillosis
Annual Review of Medicine, 1999Allergic bronchopulmonary aspergillosis (ABPA) is a syndrome seen in patients with asthma and cystic fibrosis. It is characterized by chronic colonization of the airways with a ubiquitous fungus, Aspergillus fumigatus. The clinical expression of ABPA results from the complex interaction of chronic colonization of the airways with A.
B A, Cockrill, C A, Hales
openaire +2 more sources
Allergic Bronchopulmonary Aspergillosis
Respiration, 1978Allergic bronchopulmonary aspergillosis (ABPA) is not a common condition, even though asthma due to sensitization to Aspergillus antigen is very common in many countries because of the ubiquitous distribution of the fungus itself. During the course of 14 years, the Mycology Department of the V. P.
T G, Radha, R, Viswanathan
openaire +4 more sources
Allergic Bronchopulmonary Aspergillosis
Chest, 2009Allergic bronchopulmonary aspergillosis (ABPA) is an immunologic pulmonary disorder caused by hypersensitivity to Aspergillus fumigatus. Clinically, a patient presents with chronic asthma, recurrent pulmonary infiltrates, and bronchiectasis. The population prevalence of ABPA is not clearly known, but the prevalence in asthma clinics is reported to be ...
Viswanath P. Kurup, Alan P. Knutsen
openaire +3 more sources
International Archives of Allergy and Immunology, 2020
Background: Allergic bronchopulmonary aspergillosis (ABPA) develops in the presence of predisposing conditions such as asthma and cystic fibrosis. Even ABPA accompanied by asthma is often complicated by chronic Pseudomonas aeruginosa or nontuberculous ...
K. Tomomatsu +6 more
semanticscholar +1 more source
Background: Allergic bronchopulmonary aspergillosis (ABPA) develops in the presence of predisposing conditions such as asthma and cystic fibrosis. Even ABPA accompanied by asthma is often complicated by chronic Pseudomonas aeruginosa or nontuberculous ...
K. Tomomatsu +6 more
semanticscholar +1 more source
Allergic Bronchopulmonary Aspergillosis
Chest, 2000Allergic bronchopulmonary aspergillosis (ABPA) is an immunologic bronchopulmonary inflammation due to an immune response of the lower respiratory tract against Aspergillus fumigatus. The major clinical features of ABPA include asthma, recurrent pulmonary infiltrates, immediate wheal and flare skin reactivity to A.
Roy Patterson +2 more
openaire +3 more sources
Obstructive lung diseases and allergic bronchopulmonary aspergillosis.
Current opinion in pulmonary medicine, 2020PURPOSE OF REVIEW Allergic bronchopulmonary aspergillosis (ABPA) is a disease frequently complicating asthma and cystic fibrosis. ABPA is increasingly recognized in other obstructive lung diseases (OLDs), including chronic obstructive pulmonary disease ...
V. Muthu +5 more
semanticscholar +1 more source
Treatment of allergic bronchopulmonary aspergillosis: from evidence to practice.
Future Microbiology, 2020Allergic bronchopulmonary aspergillosis (ABPA) is a complex pulmonary disorder caused by dysregulated immune responses against Aspergillus fumigatus. The disorder usually complicates the course of patients with asthma and cystic fibrosis.
S. Dhooria +3 more
semanticscholar +1 more source
Allergic Bronchopulmonary Aspergillosis
Clinical Reviews in Allergy & Immunology, 2002Allergic bronchopulmonary aspergillosis (ABPA) is a common complication of cystic fibrosis (CF), occurring in approximately 10% of patients and accompanying/accounting for approximately 10% of pulmonary exacerbations. ABPA pathogenesis is dependent upon impaired clearance and dense respiratory epithelial exposure to A fumigatus (Af) spores with ...
openaire +2 more sources
Mycoses (Berlin), 2019
Vitamin D has been demonstrated to have an immunomodulatory role in cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Herein, we evaluate supplemental vitamin D in acute‐stage ABPA complicating asthma.
M. H. Dodamani +9 more
semanticscholar +1 more source
Vitamin D has been demonstrated to have an immunomodulatory role in cystic fibrosis with allergic bronchopulmonary aspergillosis (ABPA). Herein, we evaluate supplemental vitamin D in acute‐stage ABPA complicating asthma.
M. H. Dodamani +9 more
semanticscholar +1 more source